{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:08:30Z","timestamp":1793714910954,"version":"4.6.1"},"reference-count":247,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T00:00:00Z","timestamp":1618531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>\n                    <jats:italic>P. aeruginosa<\/jats:italic>\n                    is classified as a priority one pathogen by the World Health Organisation, and new drugs are urgently needed, due to the emergence of multidrug-resistant (MDR) strains. Antimicrobial-resistant nosocomial pathogens such as\n                    <jats:italic>P. aeruginosa<\/jats:italic>\n                    pose unwavering and increasing threats. Antimicrobial stewardship has been a challenge during the COVID-19 pandemic, with a majority of those hospitalized with SARS-CoV2 infection given antibiotics as a safeguard against secondary bacterial infection. This increased usage, along with increased handling of sanitizers and disinfectants globally, may further accelerate the development and spread of cross-resistance to antibiotics. In addition,\n                    <jats:italic>P. aeruginosa<\/jats:italic>\n                    is the primary causative agent of morbidity and mortality in people with the life-shortening genetic disease cystic fibrosis (CF). Prolonged periods of selective pressure, associated with extended antibiotic treatment and the actions of host immune effectors, results in widespread adaptive and acquired resistance in\n                    <jats:italic>P. aeruginosa<\/jats:italic>\n                    found colonizing the lungs of people with CF. This review discusses the arsenal of resistance mechanisms utilized by\n                    <jats:italic>P. aeruginosa<\/jats:italic>\n                    , how these operate under high-stress environments such as the CF lung and how their interconnectedness can result in resistance to multiple antibiotic classes. Intrinsic, adaptive and acquired resistance mechanisms will be described, with a focus on how each layer of resistance can serve as a building block, contributing to multi-tiered resistance to antimicrobial activity. Recent progress in the development of anti-resistance adjuvant therapies, targeting one or more of these building blocks, should lead to novel strategies for combatting multidrug resistant\n                    <jats:italic>P. aeruginosa.<\/jats:italic>\n                    Anti-resistance adjuvant therapy holds great promise, not least because resistance against such therapeutics is predicted to be rare. The non-bactericidal nature of anti-resistance adjuvants reduce the selective pressures that drive resistance. Anti-resistance adjuvant therapy may also be advantageous in facilitating efficacious use of traditional antimicrobials, through enhanced penetration of the antibiotic into the bacterial cell. Promising anti-resistance adjuvant therapeutics and targets will be described, and key remaining challenges highlighted. As antimicrobial stewardship becomes more challenging in an era of emerging and re-emerging infectious diseases and global conflict, innovation in antibiotic adjuvant therapy can play an important role in extending the shelf-life of our existing antimicrobial therapeutic agents.\n                  <\/jats:p>","DOI":"10.3389\/fcimb.2021.665759","type":"journal-article","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T13:29:09Z","timestamp":1618579749000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":240,"title":["The Building Blocks of Antimicrobial Resistance in Pseudomonas aeruginosa: Implications for Current Resistance-Breaking Therapies"],"prefix":"10.3389","volume":"11","author":[{"given":"R. Fr\u00e8di","family":"Langendonk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne L.","family":"Fothergill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,16]]},"reference":[{"key":"B1","unstructured":"WHO publishes list of bacteria for which new antibiotics are urgently needed"},{"key":"B2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12866-019-1418-6","article-title":"Genome plasticity favours double chromosomal Tn4401b-bla KPC-2 transposon insertion in the Pseudomonas aeruginosa ST235 clone","volume":"19","author":"Abril","year":"2019","journal-title":"BMC Microbiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1574-6968.2001.tb10642.x","article-title":"Multiple facets of bacterial porins","volume":"199","author":"Achouak","year":"2006","journal-title":"FEMS Microbiol. Lett."},{"key":"B4","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1089\/mdr.2012.0223","article-title":"Dissemination of Aminoglycoside-Modifying Enzymes and 16S rRNA Methylases Among Acinetobacter baumannii and Pseudomonas aeruginosa Isolates","volume":"19","author":"Aghazadeh","year":"2013","journal-title":"Microb. Drug Resist."},{"key":"B5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.meegid.2014.03.018","article-title":"Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-\u03b2-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients","volume":"24","author":"Aghazadeh","year":"2014","journal-title":"Infect. Genet. Evol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ijantimicag.2011.09.012","article-title":"In vitro activity of avibactam (NXL104) in combination with \u03b2-lactams against Gram-negative bacteria, including OXA-48 \u03b2-lactamase-producing Klebsiella pneumoniae","volume":"39","author":"Akta\u015f","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.02752","article-title":"Role of the multidrug resistance efflux pump MexCD-OprJ in the Pseudomonas aeruginosa quorum sensing response","volume":"9","author":"Alcalde-Rico","year":"2018","journal-title":"Front. Microbiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of Quinolone Action and Resistance","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"key":"B9","doi-asserted-by":"publisher","first-page":"6949","DOI":"10.2147\/IJN.S141709","article-title":"Efficacy of neutral and negatively charged liposome-loaded gentamicin on planktonic bacteria and biofilm communities","volume":"12","author":"Alhariri","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"B10","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1002\/pro.343","article-title":"Critical biophysical properties in the Pseudomonas aeruginosa efflux gene regulator MexR are targeted by mutations conferring multidrug resistance","volume":"19","author":"Andr\u00e9sen","year":"2010","journal-title":"Protein Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1054\/drup.2001.0197","article-title":"Aminoglycoside-modifying enzymes: Mechanisms of catalytic processes and inhibition","volume":"4","author":"Azucena","year":"2001","journal-title":"Drug Resist. Update"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02406-17","article-title":"Inactivation of the pseudomonas-derived cephalosporinase-3 (PDC-3) by Relebactam","volume":"62","author":"Barnes","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B13","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ijantimicag.2016.06.023","article-title":"Molecular mechanisms of polymyxin resistance: knowns and unknowns","volume":"48","author":"Baron","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B14","doi-asserted-by":"publisher","first-page":"5196","DOI":"10.1128\/JB.174.16.5196-5203.1992","article-title":"Reevaluation, using intact cells, of the exclusion limit and role of porin OprF in Pseudomonas aeruginosa outer membrane permeability","volume":"174","author":"Bellido","year":"1992","journal-title":"J. Bacteriol."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01835-17","article-title":"Mutations in Gene fusA1 as a Novel Mechanism of Aminoglycoside Resistance in Clinical Strains of Pseudomonas aeruginosa","volume":"62","author":"Bolard","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B16","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.ijmm.2010.08.012","article-title":"Murine models of acute and chronic lung infection with cystic fibrosis pathogens","volume":"300","author":"Bragonzi","year":"2010","journal-title":"Int. J. Med. Microbiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-04996-x","article-title":"Evolutionary trade-offs associated with loss of PmrB function in host-adapted Pseudomonas aeruginosa","volume":"9","author":"Bricio-Moreno","year":"2018","journal-title":"Nat. Commun."},{"key":"B18","doi-asserted-by":"publisher","first-page":"4746","DOI":"10.1128\/JB.181.16.4746-4754.1999","article-title":"Influence of a putative ECF sigma factor on expression of the major outer membrane protein, OprF, in Pseudomonas aeruginosa and Pseudomonas fluorescens","volume":"181","author":"Brinkman","year":"1999","journal-title":"J. Bacteriol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1128\/AAC.01581-12","article-title":"Quantitative contributions of target alteration and decreased drug accumulation to pseudomonas aeruginosa fluoroquinolone resistance","volume":"57","author":"Bruchmann","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B20","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.jsps.2019.11.021","article-title":"Association of OprF mutant and disturbance of biofilm and pyocyanin virulence in pseudomonas aeruginosa","volume":"28","author":"Bukhari","year":"2020","journal-title":"Saudi Pharm. J."},{"key":"B21","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1128\/AAC.01009-09","article-title":"Updated functional classification of \u03b2-lactamases","volume":"54","author":"Bush","year":"2010","journal-title":"Antimicrobial. Agents Chemother."},{"key":"B22","doi-asserted-by":"publisher","first-page":"8859","DOI":"10.1007\/s00253-020-10859-7","article-title":"Optimization of nitric oxide donors for investigating biofilm dispersal response in Pseudomonas aeruginosa clinical isolates","volume":"104","author":"Cai","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1128\/AAC.00268-13","article-title":"Changes to its peptidoglycan-remodeling enzyme repertoire modulate \u03b2-lactam resistance in Pseudomonas aeruginosa","volume":"57","author":"Cavallari","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-15081-7","article-title":"A megaplasmid family driving dissemination of multidrug resistance in Pseudomonas","volume":"11","author":"Cazares","year":"2020","journal-title":"Nat. Commun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1128\/JCM.37.6.1771-1776.1999","article-title":"The Calgary Biofilm Device: New technology for rapid determination of antibiotic susceptibilities of bacterial biofilms","volume":"37","author":"Ceri","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.molimm.2012.09.011","article-title":"Mechanisms of immune dysfunction and bacterial persistence in non-cystic fibrosis bronchiectasis","volume":"55","author":"Chalmers","year":"2013","journal-title":"Mol. Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"769","DOI":"10.2217\/fmb.13.47","article-title":"Phage cocktails and the future of phage therapy","volume":"8","author":"Chan","year":"2013","journal-title":"Future Microbiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep26717","article-title":"Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa","volume":"6","author":"Chan","year":"2016","journal-title":"Sci. Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1111\/mmi.13346","article-title":"Novobiocin binding to NalD induces the expression of the MexAB-OprM pump in Pseudomonas aeruginosa","volume":"100","author":"Chen","year":"2016","journal-title":"Mol. Microbiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/femsre\/fux020","article-title":"Structure, function and regulation of Pseudomonas aeruginosa porins","volume":"41","author":"Chevalier","year":"2017","journal-title":"FEMS Microbiol. Rev."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e0149156","DOI":"10.1371\/journal.pone.0149156","article-title":"Premature Termination of MexR Leads to Overexpression of MexAB-OprM Efflux Pump in Pseudomonas aeruginosa in a Tertiary Referral Hospital in India","volume":"11","author":"Choudhury","year":"2016","journal-title":"PloS One"},{"key":"B32","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s00239-019-09914-3","article-title":"Antimicrobial Resistance in Bacteria: Mechanisms, Evolution, and Persistence","volume":"88","author":"Christaki","year":"2020","journal-title":"J. Mol. Evol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep21465","article-title":"Tracking the immunopathological response to Pseudomonas aeruginosa during respiratory infections","volume":"6","author":"Cigana","year":"2016","journal-title":"Sci. Rep."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01999-19","article-title":"Multidrug adaptive resistance of Pseudomonas aeruginosa swarming cells","volume":"64","author":"Coleman","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"B35","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jmb.2005.06.029","article-title":"The structural basis for substrate specificity in DNA topoisomerase IV","volume":"351","author":"Corbett","year":"2005","journal-title":"J. Mol. Biol."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00200-17","article-title":"Potentiation of antibiotic activity by a novel cationic peptide: Potency and spectrum of activity of SPR741","volume":"61","author":"Corbett","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B37","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/S0966-842X(00)01918-1","article-title":"Cystic fibrosis pathogenesis and the role of biofilms in persistent infection","volume":"9","author":"Costerton","year":"2001","journal-title":"Trends Microbiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"18520","DOI":"10.1039\/C8NR04748K","article-title":"All-in-one NIR-activated nanoplatforms for enhanced bacterial biofilm eradication","volume":"10","author":"Dai","year":"2018","journal-title":"Nanoscale"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00490-18","article-title":"Pharmacokinetics, tolerability, and safety of murepavadin, a novel antipseudomonal antibiotic, in subjects with mild, moderate, or severe renal function impairment","volume":"62","author":"Dale","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10731","article-title":"Tripartite assembly of RND multidrug efflux pumps","volume":"7","author":"Daury","year":"2016","journal-title":"Nat. Commun."},{"key":"B41","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1462-2920.2008.01792.x","article-title":"Quorum sensing in Pseudomonas aeruginosa biofilms","volume":"11","author":"de Kievit","year":"2009","journal-title":"Environ. Microbiol."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01589-17","article-title":"Genomics and susceptibility profiles of extensively drug-resistant pseudomonas aeruginosa isolates from Spain","volume":"61","author":"Del Barrio-Tofi\u00f1o","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B43","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12864-015-2244-3","article-title":"The properties of spontaneous mutations in the opportunistic pathogen Pseudomonas aeruginosa","volume":"17","author":"Dettman","year":"2016","journal-title":"BMC Genomics"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02204-19","article-title":"Activity of Antibiotics against Pseudomonas aeruginosa in an In Vitro Model of Biofilms in the Context of Cystic Fibrosis: Influence of the Culture Medium","volume":"64","author":"Diaz Iglesias","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"B45","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1099\/mic.0.000860","article-title":"Microbe profile: Pseudomonas aeruginosa: Opportunistic pathogen and lab rat","volume":"166","author":"Diggle","year":"2020","journal-title":"Microbiol. (United Kingdom)"},{"key":"B46","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1086\/518605","article-title":"16S Ribosomal RNA Methylation: Emerging Resistance Mechanism against Aminoglycosides","volume":"45","author":"Doi","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e31092","DOI":"10.1371\/journal.pone.0031092","article-title":"The Pseudomonas aeruginosa Transcriptome in Planktonic Cultures and Static Biofilms Using RNA Sequencing","volume":"7","author":"D\u00f6tsch","year":"2012","journal-title":"PloS One"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00660","article-title":"Interaction of antibacterial compounds with RND efflux pumps in Pseudomonas aeruginosa","volume":"6","author":"Dreier","year":"2015","journal-title":"Front. Microbiol."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1128\/.61.3.377-392.1997","article-title":"DNA Gyrase, Topoisomerase IV, and the 4-Quinolones","volume":"61","author":"Drlica","year":"1997","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"B50","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/S1369-5274(99)00008-9","article-title":"Mechanism of fluoroquinolone action","volume":"2","author":"Drlica","year":"1999","journal-title":"Curr. Opin. Microbiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/j.1747-0285.2012.01433.x","article-title":"Design, Facile Synthesis, and Antibacterial Activity of Hybrid 1,3,4-thiadiazole-1,3,5-triazine Derivatives Tethered via -S- Bridge","volume":"80","author":"Dubey","year":"2012","journal-title":"Chem. Biol. Drug Des."},{"key":"B52","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10096-009-0852-z","article-title":"The relative contribution of efflux and target gene mutations to fluoroquinolone resistance in recent clinical isolates of Pseudomonas aeruginosa","volume":"29","author":"Dunham","year":"2010","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"39211","DOI":"10.1074\/jbc.M111.280933","article-title":"Structural basis for the interaction of lipopolysaccharide with outer membrane protein H (OprH) from Pseudomonas aeruginosa","volume":"286","author":"Edrington","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.2217\/fmb.15.48","article-title":"Pseudomonas aeruginosa: Arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies","volume":"10","author":"El Zowalaty","year":"2015","journal-title":"Future Microbiol."},{"key":"B55","volume-title":"Surveillance of antimicrobial resistance in Europe Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2017. ECDC: Surveillance Report","year":"2018"},{"key":"B56","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1128\/JB.183.3.807-812.2001","article-title":"MexR repressor of the mexAB-oprM multidrug efflux operon of Pseudomonas aeruginosa: Identification of MexR binding sites in the mexA-mexR intergenic region","volume":"183","author":"Evans","year":"2001","journal-title":"J. Bacteriol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.drup.2010.05.002","article-title":"Resistance to polymyxins: Mechanisms, frequency and treatment options","volume":"13","author":"Falagas","year":"2010","journal-title":"Drug Resist. Update"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0012669","article-title":"Mucoidy, quorum sensing, mismatch repair and antibiotic resistance in pseudomonas aeruginosa from cystic fibrosis chronic airways infections","volume":"5","author":"Feliziani","year":"2010","journal-title":"PloS One"},{"key":"B59","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jgar.2016.11.012","article-title":"Epidemiology and resistance characteristics of Pseudomonas aeruginosa isolates from the respiratory department of a hospital in China","volume":"8","author":"Feng","year":"2017","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"B60","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1128\/AAC.00242-10","article-title":"Adaptive resistance to the \u2018last hope\u2019 antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS","volume":"54","author":"Fern\u00e1ndez","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B61","doi-asserted-by":"publisher","first-page":"6212","DOI":"10.1128\/AAC.01530-12","article-title":"The two-component system CprRS senses cationic peptides and triggers adaptive resistance in Pseudomonas aeruginosa independently of ParRS","volume":"56","author":"Fern\u00e1ndez","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.125954","article-title":"A glycopolymer improves vascoelasticity and mucociliary transport of abnormal cystic fibrosis mucus","volume":"4","author":"Fernandez-Petty","year":"2019","journal-title":"JCI Insight"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1128\/IAI.00850-10","article-title":"Full virulence of Pseudomonas aeruginosa requires OprF","volume":"79","author":"Fito-Boncompte","year":"2011","journal-title":"Infect. Immun."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01301","article-title":"Identification of a Novel Polyamine Scaffold With Potent Efflux Pump Inhibition Activity Toward Multi-Drug Resistant Bacterial Pathogens","volume":"9","author":"Fleeman","year":"2018","journal-title":"Front. Microbiol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1021\/acs.jmedchem.6b01025","article-title":"Disulfide Bond-Containing Ajoene Analogues As Novel Quorum Sensing Inhibitors of Pseudomonas aeruginosa","volume":"60","author":"Fong","year":"2017","journal-title":"J. Med. Chem."},{"key":"B66","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1128\/AAC.00138-11","article-title":"Isolation of Pseudomonas aeruginosa coproducing metallo-\u03b2-lactamase SPM-1 and 16S rRNA methylase RmtD1 in an urban river","volume":"55","author":"Fontes","year":"2011","journal-title":"Antimicrobial. Agents Chemother."},{"key":"B67","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1099\/jmm.0.015875-0","article-title":"Fluctuations in phenotypes and genotypes within populations of Pseudomonas aeruginosa in the cystic fibrosis lung during pulmonary exacerbations","volume":"59","author":"Fothergill","year":"2010","journal-title":"J. Med. Microbiol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"4780","DOI":"10.1038\/ncomms5780","article-title":"Pseudomonas aeruginosa adaptation in the nasopharyngeal reservoir leads to migration and persistence in the lungs","volume":"5","author":"Fothergill","year":"2014","journal-title":"Nat. Commun."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1128\/AAC.04607-14","article-title":"Identification of aminoglycoside-resistant Pseudomonas aeruginosa producing RmtG 16S rRNA Methyltransferase in a cystic fibrosis patient","volume":"59","author":"Francisco","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B70","doi-asserted-by":"publisher","first-page":"4478","DOI":"10.1128\/AAC.01072-08","article-title":"MexCD-OprJ multidrug efflux system of Pseudomonas aeruginosa: Involvement in chlorhexidine resistance and induction by membrane-damaging agents dependent upon the AlgU stress response sigma factor","volume":"52","author":"Fraud","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"B71","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/2049-632X.12033","article-title":"Pseudomonas aeruginosa: New insights into pathogenesis and host defenses","volume":"67","author":"Gellatly","year":"2013","journal-title":"Pathog. Dis."},{"key":"B72","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.meegid.2016.08.022","article-title":"Contribution of mexAB-oprM and mexXY (-oprA) efflux operons in antibiotic resistance of clinical Pseudomonas aeruginosa isolates in Tabriz, Iran","volume":"45","author":"Goli","year":"2016","journal-title":"Infect. Genet. Evol."},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00066-18","article-title":"Phage therapy in the postantibiotic era","volume":"32","author":"Gordillo Altamirano","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"B74","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nature17199","article-title":"Structural basis of outer membrane protein insertion by the BAM complex","volume":"531","author":"Gu","year":"2016","journal-title":"Nature"},{"key":"B75","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1093\/emph\/eoaa026","article-title":"Phage steering of antibiotic-resistance evolution in the bacterial pathogen Pseudomonas aeruginosa","volume":"2020","author":"Gurney","year":"2020","journal-title":"Evol. Med. Public Heal."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.4161\/rna.25984","article-title":"Indigenous and acquired modifications in the aminoglycoside binding sites of Pseudomonas aeruginosa rRNAs","volume":"10","author":"Gutierrez","year":"2013","journal-title":"RNA Biol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1128\/JB.145.1.628-631.1981","article-title":"Pseudomonas aeruginosa outer membrane: Peptidoglycan-associated proteins","volume":"145","author":"Hancock","year":"1981","journal-title":"J. Bacteriol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.tim.2008.12.003","article-title":"Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways","volume":"17","author":"Hassett","year":"2009","journal-title":"Trends Microbiol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s12275-014-4068-2","article-title":"Chronic Obstructive Pulmonary Disease (COPD): Evaluation From Clinical, Immunological and Bacterial Pathogenesis Perspectives","volume":"52","author":"Hassett","year":"2014","journal-title":"J. Microbiol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.drup.2016.06.007","article-title":"Multidrug efflux pumps as main players in intrinsic and acquired resistance to antimicrobials","volume":"28","author":"Hernando-Amado","year":"2016","journal-title":"Drug Resist. Updates"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1038\/s41564-019-0503-9","article-title":"Defining and combating antibiotic resistance from One Health and Global Health perspectives","volume":"4","author":"Hernando-Amado","year":"2019","journal-title":"Nat. Microbiol."},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.00025","article-title":"Naringenin Inhibition of the Pseudomonas aeruginosa Quorum Sensing Response Is Based on Its Time-Dependent Competition With N-(3-Oxo-dodecanoyl)-L-homoserine Lactone for LasR Binding","volume":"7","author":"Hernando-Amado","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0924-8579(03)00009-8","article-title":"Mutations in GyrA, ParC, MexR and NfxB in clinical isolates of Pseudomonas aeruginosa","volume":"21","author":"Higgins","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B84","doi-asserted-by":"publisher","first-page":"5085","DOI":"10.1128\/JCM.43.10.5085-5090.2005","article-title":"Antibiotic susceptibilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions","volume":"43","author":"Hill","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3390\/jfb10020026","article-title":"Formulation of antimicrobial tobramycin loaded PLGA nanoparticles via complexation with AOT","volume":"10","author":"Hill","year":"2019","journal-title":"J. Funct. Biomater."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1128\/AAC.47.4.1371-1375.2003","article-title":"MexXy-OprM efflux pump is necessary for adaptive resistance of Pseudomonas aeruginosa to aminoglycosides","volume":"47","author":"Hocquet","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1128\/AAC.50.4.1347-1351.2006","article-title":"Involvement of the MexXY-OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa","volume":"50","author":"Hocquet","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.2217\/fmb.10.125","article-title":"Pseudomonas aeruginosa biofilms in cystic fibrosis","volume":"5","author":"H\u00f8iby","year":"2010","journal-title":"Future Microbiol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1128\/AAC.05919-11","article-title":"Ajoene, a Sulfur-Rich Molecule from Garlic, Inhibits Genes Controlled by Quorum Sensing","author":"Holm Jakobsen","year":"2012"},{"key":"B90","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1016\/j.ymthe.2017.06.021","article-title":"Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis","volume":"25","author":"Howlin","year":"2017","journal-title":"Mol. Ther."},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1983","article-title":"How covid-19 is accelerating the threat of antimicrobial resistance","volume":"369","author":"Hsu","year":"2020","journal-title":"BMJ"},{"key":"B92","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1469-0691.2008.02097.x","article-title":"Chromosomal mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients","volume":"15","author":"Islam","year":"2009","journal-title":"Clin. Microbiol. Infect."},{"key":"B93","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1086\/428052","article-title":"Mechanisms of Resistance to Quinolones","volume":"41","author":"Jacoby","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-09886-8","article-title":"A broad range quorum sensing inhibitor working through sRNA inhibition","volume":"7","author":"Jakobsen","year":"2017","journal-title":"Sci. Rep."},{"key":"B95","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1128\/AAC.01511-05","article-title":"Detection of extended-spectrum \u03b2-lactamases in clinical isolates of Pseudomonas aeruginosa","volume":"50","author":"Jiang","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13002","article-title":"The evolution of antimicrobial peptide resistance in Pseudomonas aeruginosa is shaped by strong epistatic interactions","volume":"7","author":"Jochumsen","year":"2016","journal-title":"Nat. Commun."},{"key":"B97","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1749-6632.2012.06813.x","article-title":"Bacterial cell-wall recycling","volume":"1277","author":"Johnson","year":"2013","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B98","doi-asserted-by":"publisher","first-page":"4733","DOI":"10.1128\/AAC.49.11.4733-4738.2005","article-title":"Molecular mechanisms of \u03b2-lactam resistance mediated by AmpC hyperproduction in Pseudomonas aeruginosa clinical strains","volume":"49","author":"Juan","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"B99","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.biotechadv.2012.10.004","article-title":"Quorum sensing inhibitors: An overview","volume":"31","author":"Kalia","year":"2013","journal-title":"Biotechnol. Adv."},{"key":"B100","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1097\/MCP.0b013e32834b14c9","article-title":"New animal models of cystic fibrosis: What are they teaching us","volume":"17","author":"Keiser","year":"2011","journal-title":"Curr. Opin. Pulm. Med."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1074\/mcp.M113.030999","article-title":"Sialylation of outer membrane porin protein D: A mechanistic basis of antibiotic uptake in Pseudomonas aeruginosa","volume":"13","author":"Khatua","year":"2014","journal-title":"Mol. Cell. Proteomics"},{"key":"B102","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1046\/j.1365-2958.1997.2281594.x","article-title":"Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa","volume":"23","author":"K\u00f6hler","year":"1997","journal-title":"Mol. Microbiol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1128\/AAC.43.2.424","article-title":"Carbapenem activities against Pseudomonas aeruginosa: Respective contributions of OprD and efflux systems","volume":"43","author":"K\u00f6hler","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01024-17","article-title":"Hyperbaric oxygen sensitizes anoxic Pseudomonas aeruginosa biofilm to ciprofloxacin","volume":"61","author":"Kolpen","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B105","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0176-6724(87)80166-9","article-title":"Membrane permeability of Pseudomonas aeruginosa to 4-quinolones","volume":"265","author":"Kubesch","year":"1987","journal-title":"Zentralbl.  Bakteriol. Mikrobiol.  Hyg.  Abt. 1 Orig. A"},{"key":"B106","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.1021\/acs.biochem.6b00630","article-title":"Molecular Interactions of Lipopolysaccharide with an Outer Membrane Protein from Pseudomonas aeruginosa Probed by Solution NMR","volume":"55","author":"Kucharska","year":"2016","journal-title":"Biochemistry"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2011.00118","article-title":"Genetic and Functional Diversity of Pseudomonas aeruginosa Lipopolysaccharide","volume":"2","author":"Lam","year":"2011","journal-title":"Front. Microbiol."},{"key":"B108","first-page":"22","article-title":"Mechanisms of antibiotic resistance in Pseudomonas aeruginosa","volume":"95","author":"Lambert","year":"2002","journal-title":"J. R. Soc. Med. Suppl."},{"key":"B109","doi-asserted-by":"publisher","first-page":"103550","DOI":"10.1016\/j.bioorg.2019.103550","article-title":"Design, synthesis and biological evaluation of novel DNA gyrase inhibitors and their siderophore mimic conjugates","volume":"95","author":"Lamut","year":"2020","journal-title":"Bioorg. Chem."},{"key":"B110","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1365-2958.2005.04941.x","article-title":"Mucin-Pseudomonas aeruginosa interactions promote biofilm formation and antibiotic resistance","volume":"59","author":"Landry","year":"2006","journal-title":"Mol. Microbiol."},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180121","article-title":"Prevalence of ESBL-producing Pseudomonas aeruginosa isolates in Warsaw, Poland, detected by various phenotypic and genotypic methods","author":"Laudy","year":"2017"},{"key":"B112","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ijantimicag.2004.11.012","article-title":"Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa","volume":"25","author":"Lee","year":"2005","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B113","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.1021\/ja309036q","article-title":"Reactions of all escherichia coli lytic transglycosylases with bacterial cell wall","volume":"135","author":"Lee","year":"2013","journal-title":"J. Am. Chem. Soc"},{"key":"B114","doi-asserted-by":"publisher","first-page":"6882","DOI":"10.1002\/anie.201601693","article-title":"Muropeptides in Pseudomonas aeruginosa and their Role as Elicitors of \u03b2-Lactam-Antibiotic Resistance","volume":"55","author":"Lee","year":"2016","journal-title":"Angew. Chem.  Int. Ed."},{"key":"B115","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0167-4781(98)00126-2","article-title":"DNA gyrase and topoisomerase IV: Biochemical activities, physiological roles during chromosome replication, and drug sensitivities","volume":"1400","author":"Levine","year":"1998","journal-title":"Biochim. Biophys. Acta  Gene Struct. Expression"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1128\/AAC.39.9.1948","article-title":"Role of MexA-MexB-OprM in antibiotic efflux in Pseudomonas aeruginosa","volume":"39","author":"Li","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3390\/md17010043","article-title":"Synthesis and Evaluation of a Chitosan Oligosaccharide-Streptomycin Conjugate against Pseudomonas aeruginosa Biofilms","volume":"17","author":"Li","year":"2019","journal-title":"Mar. Drugs"},{"key":"B118","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1128\/CMR.00040-09","article-title":"Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms","volume":"22","author":"Lister","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"B119","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/jac\/48.suppl_1.59","article-title":"Detection of \u03b2-lactamase-mediated resistance","volume":"48","author":"Livermore","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1128\/AAC.48.5.1797-1802.2004","article-title":"Clinical Strains of Pseudomonas aeruginosa Overproducing MexAB-OprM and MexXY Efflux Pumps Simultaneously","volume":"48","author":"Llanes","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1093\/jac\/dkt115","article-title":"Diversity of \u03b2-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study","volume":"68","author":"Llanes","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"B122","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.bcp.2005.12.008","article-title":"Practical applications and feasibility of efflux pump inhibitors in the clinic - A vision for applied use","volume":"71","author":"Lomovskaya","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071001","article-title":"Clonal Dissemination, Emergence of Mutator Lineages and Antibiotic Resistance Evolution in Pseudomonas aeruginosa Cystic Fibrosis Chronic Lung Infection","volume":"8","author":"L\u00f3pez-Causap\u00e9","year":"2013","journal-title":"PloS One"},{"key":"B124","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41586-019-1665-6","article-title":"Chimeric peptidomimetic antibiotics against Gram-negative bacteria","volume":"576","author":"Luther","year":"2019","journal-title":"Nature"},{"key":"B125","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1099\/00221287-146-10-2543","article-title":"Role of Pseudomonas aeruginosa Phop-PhoQ in resistance to antimicrobial cationic peptides and aminoglycosides","volume":"146","author":"Macfarlene","year":"2000","journal-title":"Microbiology"},{"key":"B126","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1086\/315312","article-title":"Aminoglycoside-Resistance Mechanisms for Cystic Fibrosis Pseudomonas aeruginosa Isolates Are Unchanged by Long-Term, Intermittent, Inhaled Tobramycin Treatment","volume":"181","author":"MacLeod","year":"2000","journal-title":"J. Infect. Dis."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mBio.01615-20","article-title":"Outer membrane disruption overcomes intrinsic, acquired, and spontaneous antibiotic resistance","volume":"11","author":"Macnair","year":"2020","journal-title":"MBio"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.2174\/0929867323666160304150522","article-title":"Current Advances in Developing Inhibitors of Bacterial Multidrug Efflux Pumps","volume":"23","author":"Mahmood","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2217\/fmb.11.128","article-title":"Providing \u03b2-lactams a helping hand: targeting the AmpC \u03b2-lactamase induction pathway","volume":"6","author":"Mark","year":"2011","journal-title":"Future Microbiol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.biochi.2005.04.012","article-title":"Bacterial efflux systems and efflux pumps inhibitors","volume":"87","author":"Marquez","year":"2005","journal-title":"Biochimie"},{"key":"B131","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/ng.3148","article-title":"Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis","volume":"47","author":"Marvig","year":"2015","journal-title":"Nat. Genet."},{"key":"B132","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1128\/AAC.44.3.658-664.2000","article-title":"Assignment of the substrate-selective subunits of the MexEF-OprN multidrug efflux pump of Pseudomonas aeruginosa","volume":"44","author":"Maseda","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"B133","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/cbdd.13695","article-title":"Potent antibacterial activity of dihydydropyrimidine-1,3,5-triazines via inhibition of DNA gyrase and antifungal activity with favourable metabolic profile","volume":"96","author":"Masih","year":"2020","journal-title":"Chem. Biol. Drug Des. cbdd.13695"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1128\/AAC.36.9.1847","article-title":"Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa","volume":"36","author":"Masuda","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"B135","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1128\/AAC.40.4.909","article-title":"Quantitative correlation between susceptibility and OprJ production in NfxB mutants of Pseudomonas aeruginosa","volume":"40","author":"Masuda","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"B136","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1128\/AAC.43.2.400","article-title":"Interplay between chromosomal \u03b2-lactamase and the MexAB-OprM efflux system in intrinsic resistance to \u03b2-lactams in Pseudomonas aeruginosa","volume":"43","author":"Masuda","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"B137","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1128\/AAC.44.12.3322-3327.2000","article-title":"Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosa","volume":"44","author":"Masuda","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"B138","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1073\/pnas.0711982105","article-title":"Dynamics of Pseudomonas aeruginosa genome evolution","volume":"105","author":"Mathee","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B139","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1165\/rcmb.2017-0321TR","article-title":"Pseudomonas aeruginosa biofilms: Host response and clinical implications in lung infections","volume":"58","author":"Maurice","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1046\/j.1365-2958.2003.03673.x","article-title":"Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa","volume":"50","author":"McPhee","year":"2003","journal-title":"Mol. Microbiol."},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.5772\/55616","article-title":"Pseudomonas aeruginosa: Multi-Drug-Resistance Development and Treatment Options","author":"Meletis","year":"2013","journal-title":"Infect. Control"},{"key":"B142","doi-asserted-by":"publisher","first-page":"6496","DOI":"10.1039\/D0FO00046A","article-title":"Vanillin inhibits PqsR-mediated virulence in: Pseudomonas aeruginosa","volume":"11","author":"Mok","year":"2020","journal-title":"Food Funct."},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2017.00039","article-title":"Pseudomonas aeruginosa lifestyle: A paradigm for adaptation, survival, and persistence","volume":"7","author":"Moradali","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1574-6968.2001.tb10794.x","article-title":"Construction of a series of mutants lacking all of the four major mex operons for multidrug efflux pumps or possessing each one of the operons from Pseudomonas aeruginosa PAO1: MexCD-OprJ is an inducible pump","volume":"202","author":"Morita","year":"2001","journal-title":"FEMS Microbiol. Lett."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1128\/AAC.05829-11","article-title":"PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patients","volume":"56","author":"Moskowitz","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000353","article-title":"\u03b2-lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein","volume":"5","author":"Moya","year":"2009","journal-title":"PloS Pathog."},{"key":"B147","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1093\/jac\/dky241","article-title":"Human airway mucus alters susceptibility of Pseudomonas aeruginosa biofilms to tobramycin, but not colistin","volume":"73","author":"M\u00fcller","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"B148","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature12300","article-title":"Structural basis for the inhibition of bacterial multidrug exporters","volume":"500","author":"Nakashima","year":"2013","journal-title":"Nature"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00498-19","article-title":"In vitro activity of a novel glycopolymer against biofilms of burkholderia cepacia complex cystic fibrosis clinical isolates","volume":"63","author":"Narayanaswamy","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01724","article-title":"Novel Glycopolymer Eradicates Antibiotic- and CCCP-Induced Persister Cells in Pseudomonas aeruginosa","volume":"9","author":"Narayanaswamy","year":"2018","journal-title":"Front. Microbiol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1128\/JB.186.10.2973-2983.2004","article-title":"Assembly of the MexAB-OprM multidrug efflux system of Pseudomonas aeruginosa: identification and characterization of mutations in mexA compromising MexA multimerization and interaction with MexB","volume":"186","author":"Nehme","year":"2004","journal-title":"J. Bacteriol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"16230","DOI":"10.1074\/jbc.M600650200","article-title":"Pseudomonas aeruginosa porin OprF. Properties of the channel","volume":"281","author":"Nestorovich","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B153","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/9780470920541.ch1","article-title":"Structure and mechanism of RND-type multidrug efflux pumps","author":"Nikaido","year":"2010","journal-title":"Adv. Enzymol. Relat. Areas Mol. Biol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/B978-0-12-386009-5.00012-6","article-title":"Emerging New Therapeutics Against Key Gram-Negative Pathogens","volume":"46","author":"Obrecht","year":"2011","journal-title":"Annu. Rep. Med. Chem."},{"key":"B155","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1128\/AAC.43.5.1085","article-title":"Negative regulation of the Pseudomonas aeruginosa outer membrane porin OprD selective for imipenem and basic amino acids","volume":"43","author":"Ochs","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"B156","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1126\/science.288.5469.1251","article-title":"High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection","volume":"288","author":"Oliver","year":"2000","journal-title":"Sci. (80-. )"},{"key":"B157","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s10096-015-2323-z","article-title":"Biofilm-specific antibiotic tolerance and resistance","volume":"34","author":"Olsen","year":"2015","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B158","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1093\/jac\/dkz149","article-title":"ESBLs and resistance to ceftazidime\/avibactam and ceftolozane\/tazobactam combinations in Escherichia coli and Pseudomonas aeruginosa","volume":"74","author":"Ortiz de la Rosa","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"B159","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1128\/JB.01623-06","article-title":"Identification of genes involved in swarming motility using a Pseudomonas aeruginosa PAO1 mini-Tn5-lux mutant library","volume":"189","author":"Overhage","year":"2007","journal-title":"J. Bacteriol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1749-6632.2012.06796.x","article-title":"Metallo-\u03b2-lactamase structure and function","volume":"1277","author":"Palzkill","year":"2013","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B161","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00203-016-1215-7","article-title":"Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa","volume":"198","author":"Pan","year":"2016","journal-title":"Arch. Microbiol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.2217\/fmb.12.88","article-title":"Pseudomonas infection in chronic obstructive pulmonary disease","volume":"7","author":"Parameswaran","year":"2012","journal-title":"Future Microbiol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"4524","DOI":"10.1021\/acs.jproteome.5b00262","article-title":"Tracking the dynamic relationship between cellular systems and extracellular subproteomes in Pseudomonas aeruginosa biofilms","volume":"14","author":"Park","year":"2015","journal-title":"J. Proteome Res."},{"key":"B164","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1089\/mdr.2011.0019","article-title":"Evaluation of Fluoroquinolone Resistance Mechanisms in Pseudomonas aeruginosa Multidrug Resistance Clinical Isolates","volume":"18","author":"Pasca","year":"2012","journal-title":"Microb. Drug Resist."},{"key":"B165","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","article-title":"Extended-spectrum \u03b2-lactamases: A clinical update","volume":"18","author":"Paterson","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"B166","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.mib.2003.08.005","article-title":"Multidrug efflux pumps and resistance: regulation and evolution","volume":"6","author":"Paulsen","year":"2003","journal-title":"Curr. Opin. Microbiol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1586\/eri.13.12","article-title":"Clinical relevance of the ESKAPE pathogens","volume":"11","author":"Pendleton","year":"2013","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"B168","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1128\/AAC.36.5.1057","article-title":"A pleiotropic, posttherapy, enoxacin-resistant mutant of Pseudomonas aeruginosa","volume":"36","author":"Piddock","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"B169","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1128\/AAC.40.9.2021","article-title":"Expression of the multidrug resistance operon mexA-mexB-oprM in Pseudomonas aeruginosa: mexR encodes a regulator of operon expression","volume":"40","author":"Poole","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"B170","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1046\/j.1365-2958.1996.281397.x","article-title":"Overexpression of the mexC-mexD-oprJ efflux operon in nfxB -type multidrug-resistant strains of Pseudomonas aeruginosa","volume":"21","author":"Poole","year":"1996","journal-title":"Mol. Microbiol."},{"key":"B171","article-title":"Multidrug Efflux Pumps and Antimicrobial Resistance in Pseudomonas aeruginosa and Related Organisms JMMB Symposium","volume":"613","author":"Poole","year":"2001","journal-title":"J. Mol. Microbiol. Biotechnol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1128\/AAC.49.2.479-487.2005","article-title":"Aminoglycoside resistance in Pseudomonas aeruginosa","volume":"49","author":"Poole","year":"2005","journal-title":"Antimicrobial. Agents Chemother."},{"key":"B173","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1128\/microbe.3.179.1","article-title":"Bacterial multidrug efflux pumps serve other functions","volume":"3","author":"Poole","year":"2008","journal-title":"Microbe"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2011.00065","article-title":"Pseudomonas aeruginosa: resistance to the max","volume":"2","author":"Poole","year":"2011","journal-title":"Front. Microbiol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1139\/cjm-2014-0666","article-title":"Stress responses as determinants of antimicrobial resistance in Pseudomonas aeruginosa: multidrug efflux and more","volume":"60","author":"Poole","year":"2014","journal-title":"Can. J. Microbiol."},{"key":"B176","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1136\/thoraxjnl-2015-208027","article-title":"Aminoglycoside resistance of Pseudomonas aeruginosa in cystic fibrosis results from convergent evolution in the mexZ gene","volume":"72","author":"Prickett","year":"2017","journal-title":"Thorax"},{"key":"B177","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1128\/AAC.44.10.2861-2864.2000","article-title":"Two efflux systems expressed simultaneously in multidrug-resistant Pseudomonas aeruginosa","volume":"44","author":"Pumbwe","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"B178","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1574-6968.1996.tb08456.x","article-title":"Role of gyrA mutation and loss of OprF in the multiple antibiotic resistance phenotype of Pseudomonas aeruginosa G49","volume":"143","author":"Pumbwe","year":"1996","journal-title":"FEMS Microbiol. Lett."},{"key":"B179","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1128\/CMR.00001-07","article-title":"Carbapenemases: The versatile \u03b2-lactamases","volume":"20","author":"Queenan","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"key":"B180","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.drup.2010.08.003","article-title":"Aminoglycoside modifying enzymes","volume":"13","author":"Ramirez","year":"2010","journal-title":"Drug Resist. Update"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01718-18","article-title":"Target (MexB)- and Efflux-Based Mechanisms Decreasing the Effectiveness of the Efflux Pump Inhibitor D13-9001 in Pseudomonas aeruginosa PAO1: Uncovering a New Role for MexMN-OprM in Efflux of \u03b2-Lactams and a Novel Regulatory Circuit (MmnRS) Controlling MexMN Expression","volume":"63","author":"Ranjitkar","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/759348","article-title":"The formation of biofilms by pseudomonas aeruginosa: A review of the natural and synthetic compounds interfering with control mechanisms","volume":"2015","author":"Rasamiravaka","year":"2015","journal-title":"BioMed. Res. Int."},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02538-18","article-title":"Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia","volume":"63","author":"Rees","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B184","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1099\/jmm.0.000873","article-title":"Mechanisms of ciprofloxacin resistance in pseudomonas aeruginosa: New approaches to an old problem","volume":"68","author":"Rehman","year":"2019","journal-title":"J. Med. Microbiol."},{"key":"B185","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1016\/S0960-894X(03)00556-0","article-title":"Conformationally-restricted analogues of efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa","volume":"13","author":"Renau","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B186","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3390\/antibiotics8040229","article-title":"Effectiveness of efflux pump inhibitors as biofilm disruptors and resistance breakers in gram- negative (ESKAPEE) bacteria","volume":"8","author":"Reza","year":"2019","journal-title":"Antibiotics"},{"key":"B187","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.ijantimicag.2014.12.029","article-title":"Carbapenem resistance in cystic fibrosis strains of Pseudomonas aeruginosa as a result of amino acid substitutions in porin OprD","volume":"45","author":"Richardot","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B188","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.1016\/j.jmb.2015.08.016","article-title":"Pseudomonas aeruginosa Biofilm Infections: Community Structure, Antimicrobial Tolerance and Immune Response","volume":"427","author":"Rybtke","year":"2015","journal-title":"J. Mol. Biol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1007\/s00018-019-03196-0","article-title":"Polyamines in mammalian pathophysiology","volume":"76","author":"S\u00e1nchez-Jim\u00e9nez","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2475067","article-title":"Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens","volume":"2016","author":"Santajit","year":"2016","journal-title":"BioMed. Res. Int."},{"key":"B191","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1574-6976.2008.00105.x","article-title":"The penicillin-binding proteins: Structure and role in peptidoglycan biosynthesis","volume":"32","author":"Sauvage","year":"2008","journal-title":"FEMS Microbiol. Rev."},{"key":"B192","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/nrmicro3525","article-title":"Outer-membrane vesicles from Gram-negative bacteria: Biogenesis and functions","volume":"13","author":"Schwechheimer","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01820-17","article-title":"Aminoarabinosylation of lipid a is critical for the development of colistin resistance in pseudomonas aeruginosa","volume":"62","author":"Sciuto","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01475","article-title":"Animal models in the pathophysiology of cystic fibrosis","volume":"9","author":"Semaniakou","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B195","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ejps.2017.05.063","article-title":"Antimicrobial activity of polymyxin-loaded solid lipid nanoparticles (PLX-SLN): Characterization of physicochemical properties and in vitro efficacy","volume":"106","author":"Severino","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"B196","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-017-0262-9","article-title":"Imipenem\/cilastatin encapsulated polymeric nanoparticles for destroying carbapenem-resistant bacterial isolates","volume":"15","author":"Shaaban","year":"2017","journal-title":"J. Nanobiotechnol."},{"key":"B197","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11373-007-9194-y","article-title":"Aminoglycosides versus bacteria - A description of the action, resistance mechanism, and nosocomial battleground","volume":"15","author":"Shakil","year":"2008","journal-title":"J. Biomed. Sci."},{"key":"B198","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ijantimicag.2010.11.019","article-title":"Adaptive resistance to cationic compounds in Pseudomonas aeruginosa","volume":"37","author":"Skiada","year":"2011","journal-title":"Int. J. Antimicrobial. Agents"},{"key":"B199","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/cc6820","article-title":"Gram-negative antibiotic resistance: there is a price to pay","author":"Slama","year":"2008","journal-title":"Crit. Care"},{"key":"B200","doi-asserted-by":"publisher","first-page":"8487","DOI":"10.1073\/pnas.0602138103","article-title":"Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients","volume":"103","author":"Smith","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B201","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1128\/JB.187.4.1246-1253.2005","article-title":"Mutations in PA2491 (mexS) promote MexT-dependent mexEF-oprN expression and multidrug resistance in a clinical strain of Pseudomonas aeruginosa","volume":"187","author":"Sobel","year":"2005","journal-title":"J. Bacteriol."},{"key":"B202","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1128\/AAC.42.1.65","article-title":"Expression of Pseudomonas aeruginosa multidrug efflux pumps mexA-mexB- OprM and MexC-MexD-OprJ in a multidrug-sensitive Escherichia coli strain","volume":"42","author":"Srikumar","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"B203","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1126\/science.1182749","article-title":"Peptidomimetic antibiotics target outer-membrane biogenesis in pseudomonas aeruginosa","volume":"327","author":"Srinivas","year":"2010","journal-title":"Science"},{"key":"B204","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1099\/jmm.0.45969-0","article-title":"Microcolony formation: A novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung","volume":"54","author":"Sriramulu","year":"2005","journal-title":"J. Med. Microbiol."},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1038\/nmicrobiol.2017.28","article-title":"Pentamidine sensitizes Gram-negative pathogens to antibiotics and overcomes acquired colistin resistance","volume":"2","author":"Stokes","year":"2017","journal-title":"Nat. Microbiol."},{"key":"B206","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/35023079","article-title":"Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen","volume":"406","author":"Stover","year":"2000","journal-title":"Nature"},{"key":"B207","doi-asserted-by":"publisher","first-page":"25","DOI":"10.18869\/modares.iem.2.1.25","article-title":"Pseudomonas aeruginosa: A review of their Pathogenesis and Prevalence in Clinical Settings and the Environment","volume":"2","author":"Streeter","year":"2016","journal-title":"Infect. Epidemiol. Med."},{"key":"B208","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1111\/j.1742-4658.2012.08481.x","article-title":"Alternative folding pathways of the major porin OprF of Pseudomonas aeruginosa","volume":"279","author":"Sugawara","year":"2012","journal-title":"FEBS J."},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00848-18","article-title":"Broad-spectrum adaptive antibiotic resistance associated with pseudomonas aeruginosa mucin-dependent surfing motility","volume":"62","author":"Sun","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1128\/JB.00394-18","article-title":"Surfing Motility: a Conserved yet Diverse Adaptation among Motile Bacteria","volume":"200","author":"Sun","year":"2018","journal-title":"Journal of Bacteriology"},{"key":"B211","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1099\/mic.0.028233-0","article-title":"Detection of 140 clinically relevant antibiotic-resistance genes in the plasmid metagenome of wastewater treatment plant bacteria showing reduced susceptibility to selected antibiotics","volume":"155","author":"Szczepanowski","year":"2009","journal-title":"Microbiology"},{"key":"B212","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/1471-2334-13-251","article-title":"Emergence of 16S rRNA methylase-producing Acinetobacter baumannii and Pseudomonas aeruginosa isolates in hospitals in Vietnam","volume":"13","author":"Tada","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"B213","doi-asserted-by":"publisher","first-page":"e0147811","DOI":"10.1371\/journal.pone.0147811","article-title":"RNASeq Based Transcriptional Profiling of Pseudomonas aeruginosa PA14 after Short- and Long-Term Anoxic Cultivation in Synthetic Cystic Fibrosis Sputum Medium","volume":"11","author":"Tata","year":"2016","journal-title":"PloS One"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2006.03.011","article-title":"Mechanisms of Antimicrobial Resistance in Bacteria","volume":"119","author":"Tenover","year":"2006","journal-title":"Am. J. Med."},{"key":"B215","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S0022-2836(03)00662-4","article-title":"The mechanism of action of macrolides, lincosamides and streptogramin B reveals the nascent peptide exit path in the ribosome","volume":"330","author":"Tenson","year":"2003","journal-title":"J. Mol. Biol."},{"key":"B216","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0163-7258(85)90062-2","article-title":"Mode of action of \u03b2-lactam antibiotics","volume":"27","author":"Tipper","year":"1985","journal-title":"Pharmacol. Ther."},{"key":"B217","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1093\/bioinformatics\/btaa009","article-title":"The Protein Imager: a full-featured online molecular viewer interface with server-side HQ-rendering capabilities","volume":"36","author":"Tomasello","year":"2020","journal-title":"Bioinformatics"},{"key":"B218","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1016\/j.jmb.2019.04.002","article-title":"\u03b2-Lactamases and \u03b2-Lactamase Inhibitors in the 21st Century","volume":"431","author":"Tooke","year":"2019","journal-title":"J. Mol. Biol."},{"key":"B219","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1128\/AAC.33.8.1202","article-title":"Decreased outer membrane permeability in imipenem-resistant mutants of Pseudomonas aeruginosa","volume":"33","author":"Trias","year":"1989","journal-title":"Antimicrob. Agents Chemother."},{"key":"B220","doi-asserted-by":"publisher","first-page":"15680","DOI":"10.1016\/S0021-9258(18)55452-1","article-title":"Protein D2 Channel of the Pseudomonas aeruginosa Outer Membrane Has a Binding Site for Basic Amino Acids and Peptides","volume":"265","author":"Triass","year":"1990","journal-title":"J. Biol. Chem."},{"key":"B221","doi-asserted-by":"publisher","first-page":"11837","DOI":"10.1021\/bi000386q","article-title":"The functional association of polymyxin B with bacterial lipopolysaccharide is stereospecific: Studies on polymyxin B nonapeptide","volume":"39","author":"Tsubery","year":"2000","journal-title":"Biochemistry"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.19509.1","article-title":"Emerging therapies against infections with pseudomonas aeruginosa [version 1; peer review: 2 approved]","volume":"8","author":"T\u00fcmmler","year":"2019","journal-title":"F1000Research"},{"key":"B223","doi-asserted-by":"publisher","first-page":"100078","DOI":"10.1016\/j.medidd.2020.100078","article-title":"Emerging peptide antibiotics with therapeutic potential","volume":"9","author":"Upert","year":"2021","journal-title":"Med. Drug Discovery"},{"key":"B224","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1093\/jac\/dkz262","article-title":"Pseudomonas aeruginosa with NDM-1, DIM-1 and PME-1 \u03b2-lactamases, and RmtD3 16S rRNA methylase, encoded by new genomic islands","volume":"74","author":"Urbanowicz","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"B225","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3390\/molecules24020249","article-title":"Polymyxin derivatives that sensitize Gram-negative bacteria to other antibiotics","volume":"24","author":"Vaara","year":"2019","journal-title":"Molecules"},{"key":"B226","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1080\/1061186X.2019.1574802","article-title":"Efficacy of intravesical targeting of novel quorum sensing inhibitor nanoparticles against Pseudomonas aeruginosa biofilm-associated murine pyelonephritis","volume":"27","author":"Vadekeetil","year":"2019","journal-title":"J. Drug Targeting"},{"key":"B227","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1258\/002367702320162405","article-title":"Murine models of chronic Pseudomonas aeruginosa lung infection","volume":"36","author":"Van Heeckeren","year":"2002","journal-title":"Lab. Anim."},{"key":"B228","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1128\/AAC.48.5.1676-1680.2004","article-title":"Role of the Multidrug Efflux System MexXY in the Emergence of Moderate Resistance to Aminoglycosides among Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis","volume":"48","author":"Vogne","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"B229","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1574-6976.2007.00094.x","article-title":"Peptidoglycan structure and architecture","volume":"32","author":"Vollmer","year":"2008","journal-title":"FEMS Microbiol. Rev."},{"key":"B230","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s00284-012-0217-1","article-title":"Influence of pseudomonas aeruginosa pvdQ gene on altering antibiotic susceptibility under swarming conditions","volume":"66","author":"Wang","year":"2013","journal-title":"Curr. Microbiol."},{"key":"B231","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s11095-018-2464-8","article-title":"Co-Delivery of Ciprofloxacin and Colistin in Liposomal Formulations with Enhanced In Vitro Antimicrobial Activities against Multidrug Resistant Pseudomonas aeruginosa","volume":"35","author":"Wang","year":"2018","journal-title":"Pharm. Res."},{"key":"B232","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1136\/thoraxjnl-2016-209265","article-title":"Phage therapy is highly effective against chronic lung infections with Pseudomonas aeruginosa","volume":"72","author":"Waters","year":"2017","journal-title":"Thorax"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029276","article-title":"Phenotypic and genome-wide analysis of an antibiotic-resistant small colony variant (SCV) of pseudomonas aeruginosa","volume":"6","author":"Wei","year":"2011","journal-title":"PloS One"},{"key":"B234","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1002\/cbic.201200276","article-title":"Inhibition of Lipopolysaccharide Transport to the Outer Membrane in Pseudomonas aeruginosa by Peptidomimetic Antibiotics","volume":"13","author":"Werneburg","year":"2012","journal-title":"ChemBioChem"},{"key":"B235","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1128\/AAC.37.1.126","article-title":"A single point mutation in the DNA gyrase A protein greatly reduces binding of fluoroquinolones to the gyrase-DNA complex","volume":"37","author":"Willmott","year":"1993","journal-title":"Antimicrobial. Agents Chemother."},{"key":"B236","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s40265-017-0725-1","article-title":"Novel Beta-Lactamase Inhibitors: Unlocking Their Potential in Therapy","volume":"77","author":"Wong","year":"2017","journal-title":"Drugs"},{"key":"B237","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.1128\/JB.171.6.3304-3309.1989","article-title":"Pseudomonas aeruginosa outer membrane protein F: Structural role and relationship to the Escherichia coli omP protein","volume":"171","author":"Woodruff","year":"1989","journal-title":"J. Bacteriol."},{"key":"B238","first-page":"201\u2014206","article-title":"GyrA mutations in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa in a Silesian Hospital in Poland","volume":"54","author":"Wydmuch","year":"2005","journal-title":"Polish J. Microbiol."},{"key":"B239","first-page":"1386","article-title":"Prevalence and fluoroquinolone resistance of pseudomonas aeruginosa in a hospital of South China","volume":"8","author":"Yang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00073-12","article-title":"Mucin promotes rapid surface motility in pseudomonas aeruginosa","volume":"3","author":"Yeung","year":"2012","journal-title":"MBio"},{"key":"B241","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/S0140-6736(03)14959-8","article-title":"Acquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa","volume":"362","author":"Yokoyama","year":"2003","journal-title":"Lancet"},{"key":"B242","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1006\/bbrc.1995.2102","article-title":"Role of Porins in the Antibiotic Susceptibility of Pseudomonas aeruginosa: Construction of Mutants with Deletions in the Multiple Porin Genes","volume":"213","author":"Yoneyama","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B243","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S1534-5807(02)00295-2","article-title":"Pseudomonas aeruginosa anaerobic respiration in biofilms: Relationships to cystic fibrosis pathogenesis","volume":"3","author":"Yoon","year":"2002","journal-title":"Dev. Cell"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.1271\/bbb.62.1014","article-title":"Antimicrobial Activity of a Compound Isolated from an Oil-Macerated Garlic Extract","volume":"62","author":"Yoshida","year":"1998","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"B245","doi-asserted-by":"publisher","first-page":"7087","DOI":"10.1016\/j.bmc.2007.07.039","article-title":"MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 7: Highly soluble and in vivo active quaternary ammonium analogue D13-9001, a potential preclinical candidate","volume":"15","author":"Yoshida","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"B246","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1080\/21691401.2016.1198362","article-title":"Evaluation and study of antimicrobial activity of nanoliposomal meropenem against Pseudomonas aeruginosa isolates","volume":"45","author":"Zahra","year":"2017","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"B247","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1093\/jac\/dkaa217","article-title":"Evaluation of the in vitro activity of new polymyxin B analogue SPR206 against clinical MDR, colistin-resistant and tigecycline-resistant Gram-negative bacilli","volume":"75","author":"Zhang","year":"2020","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2021.665759\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T13:29:24Z","timestamp":1618579764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2021.665759\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,16]]},"references-count":247,"alternative-id":["10.3389\/fcimb.2021.665759"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2021.665759","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,16]]},"article-number":"665759"}}